Key facts
- Sanius Health’s last known valuation is $30.0M (Sep 2025).
- It has raised $6.3M; the latest was Seed Round ($1.0M) in Sep 2025.
- Notable investors include Meltwind Advisory, Arāya Ventures.
- Status: Privately Held (backing).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Sanius Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Sanius Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sanius Health
Developer of a healthcare platform designed to improve rare disease treatment and advance research into rare and chronic conditions. The company's approach to improving outcomes and access to new medicines focuses on combining live remote monitoring, patient genomics, secondary care, primary care, and patient-reported data, enabling patients to manage their well-being and improve their daily outcomes.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 26
- Website
- saniushealth.com/
- Ownership
- Privately Held (backing)
Sanius Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sanius Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sanius Health in its N-PORT filings yet. We sweep new filings monthly.